{"title":"在乳腺癌以外的另一种慢性疾病中,妇女对药物的依从性和希望:一项横断面研究。","authors":"Figen Akay, Ayşe Özkaraman, Öznur Bal","doi":"10.1007/s00520-025-09939-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study was conducted to evaluate the level of hope and adherence to medication in women with breast cancer in the presence of another chronic disease.</p><p><strong>Methods: </strong>The cross-sectional study was conducted in March-August 2022 with women with breast cancer with (CVD group) and without (Non-CVD group) cardiovascular disease as a chronic disease. Data were collected with the 'Individual Information Form', 'Herth Hope Scale' and 'Medication Adherence and Prescription Writing Scale'. Independent Sample T-test, Mann Whitney U Test, Chi-Square Test and Correlation Analysis were used to analyze the data.</p><p><strong>Results: </strong>Adherence to medication levels of the patients were higher with a mean score of 8.55 ± 2.16 in the CVD group and 8.33 ± 2.14 in the Non-CVD group and there was no difference between the two groups (p < 0.05). When the hope levels of the patients were evaluated; the hope level of the CVD group was 69.57 ± 9.58 and the hope level of the Non-CVD group was 74.96 ± 7.98. The hope level of the CVD group was lower than that of the Non-CVD group (p < 0.001, Cohen's d = 0.61).</p><p><strong>Conclusion: </strong>In women, the presence of a chronic (cardiovascular) disease in addition to breast cancer does not affect medication adherence but negatively affects the level of hope.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 10","pages":"869"},"PeriodicalIF":3.0000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Women's adherence to medication and hope in the presence of another chronic disease besides breast cancer: a cross-sectional study.\",\"authors\":\"Figen Akay, Ayşe Özkaraman, Öznur Bal\",\"doi\":\"10.1007/s00520-025-09939-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study was conducted to evaluate the level of hope and adherence to medication in women with breast cancer in the presence of another chronic disease.</p><p><strong>Methods: </strong>The cross-sectional study was conducted in March-August 2022 with women with breast cancer with (CVD group) and without (Non-CVD group) cardiovascular disease as a chronic disease. Data were collected with the 'Individual Information Form', 'Herth Hope Scale' and 'Medication Adherence and Prescription Writing Scale'. Independent Sample T-test, Mann Whitney U Test, Chi-Square Test and Correlation Analysis were used to analyze the data.</p><p><strong>Results: </strong>Adherence to medication levels of the patients were higher with a mean score of 8.55 ± 2.16 in the CVD group and 8.33 ± 2.14 in the Non-CVD group and there was no difference between the two groups (p < 0.05). When the hope levels of the patients were evaluated; the hope level of the CVD group was 69.57 ± 9.58 and the hope level of the Non-CVD group was 74.96 ± 7.98. The hope level of the CVD group was lower than that of the Non-CVD group (p < 0.001, Cohen's d = 0.61).</p><p><strong>Conclusion: </strong>In women, the presence of a chronic (cardiovascular) disease in addition to breast cancer does not affect medication adherence but negatively affects the level of hope.</p>\",\"PeriodicalId\":22046,\"journal\":{\"name\":\"Supportive Care in Cancer\",\"volume\":\"33 10\",\"pages\":\"869\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Supportive Care in Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00520-025-09939-z\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Supportive Care in Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00520-025-09939-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Women's adherence to medication and hope in the presence of another chronic disease besides breast cancer: a cross-sectional study.
Purpose: This study was conducted to evaluate the level of hope and adherence to medication in women with breast cancer in the presence of another chronic disease.
Methods: The cross-sectional study was conducted in March-August 2022 with women with breast cancer with (CVD group) and without (Non-CVD group) cardiovascular disease as a chronic disease. Data were collected with the 'Individual Information Form', 'Herth Hope Scale' and 'Medication Adherence and Prescription Writing Scale'. Independent Sample T-test, Mann Whitney U Test, Chi-Square Test and Correlation Analysis were used to analyze the data.
Results: Adherence to medication levels of the patients were higher with a mean score of 8.55 ± 2.16 in the CVD group and 8.33 ± 2.14 in the Non-CVD group and there was no difference between the two groups (p < 0.05). When the hope levels of the patients were evaluated; the hope level of the CVD group was 69.57 ± 9.58 and the hope level of the Non-CVD group was 74.96 ± 7.98. The hope level of the CVD group was lower than that of the Non-CVD group (p < 0.001, Cohen's d = 0.61).
Conclusion: In women, the presence of a chronic (cardiovascular) disease in addition to breast cancer does not affect medication adherence but negatively affects the level of hope.
期刊介绍:
Supportive Care in Cancer provides members of the Multinational Association of Supportive Care in Cancer (MASCC) and all other interested individuals, groups and institutions with the most recent scientific and social information on all aspects of supportive care in cancer patients. It covers primarily medical, technical and surgical topics concerning supportive therapy and care which may supplement or substitute basic cancer treatment at all stages of the disease.
Nursing, rehabilitative, psychosocial and spiritual issues of support are also included.